Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Lasserson

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Health Technology Assessment (Winchester, England)|July 12, 2023
Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studiesJessica Harris, Koen B Pouwels, Thomas Johnson, et al.
Trials|December 12, 2022
Correction: Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trialNathan R Hill, Daniel Lasserson, Ben Thompson, et al.
Frontiers in Neurology|January 6, 2022
One-Year Risk of Stroke After Transient Ischemic Attack or Minor Stroke in Hunter New England, Australia (INSIST Study)Shinya Tomari, Christopher R Levi, Elizabeth Holliday, et al.
Frontiers in Neurology|July 17, 2020
The Characteristics of Patients With Possible Transient Ischemic Attack and Minor Stroke in the Hunter and Manning Valley Regions, Australia (the INSIST Study)Shinya Tomari, Parker Magin, Daniel Lasserson, et al.
The Australian Journal of Rural Health|November 16, 2022
Rural versus metropolitan comparison of processes of care in the community-based management of TIA and minor stroke in Australia (an analysis from the INSIST study)Shyam Gangadharan, Shinya Tomari, Christopher R Levi, et al.
The Lancet. Respiratory Medicine|July 12, 2021
Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trialTimothy S C Hinks, Lucy Cureton, Ruth Knight, et al.
Health Technology Assessment (Winchester, England)|April 11, 2025
Lessons from the PROTECT-CH COVID-19 platform trial in care homesPhilip M Bath, Jonathan Ball, Matthew Boyd, et al.
Diagnostic and Prognostic Research|May 17, 2019
Erratum to: Methods for evaluating medical tests and biomarkersGowri Gopalakrishna, Miranda Langendam, Rob Scholten, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Health Technology Assessment (Winchester, England)|July 12, 2023
Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studiesJessica Harris, Koen B Pouwels, Thomas Johnson, et al.
Trials|December 12, 2022
Correction: Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trialNathan R Hill, Daniel Lasserson, Ben Thompson, et al.
Frontiers in Neurology|January 6, 2022
One-Year Risk of Stroke After Transient Ischemic Attack or Minor Stroke in Hunter New England, Australia (INSIST Study)Shinya Tomari, Christopher R Levi, Elizabeth Holliday, et al.
Frontiers in Neurology|July 17, 2020
The Characteristics of Patients With Possible Transient Ischemic Attack and Minor Stroke in the Hunter and Manning Valley Regions, Australia (the INSIST Study)Shinya Tomari, Parker Magin, Daniel Lasserson, et al.
The Australian Journal of Rural Health|November 16, 2022
Rural versus metropolitan comparison of processes of care in the community-based management of TIA and minor stroke in Australia (an analysis from the INSIST study)Shyam Gangadharan, Shinya Tomari, Christopher R Levi, et al.
The Lancet. Respiratory Medicine|July 12, 2021
Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trialTimothy S C Hinks, Lucy Cureton, Ruth Knight, et al.
Health Technology Assessment (Winchester, England)|April 11, 2025
Lessons from the PROTECT-CH COVID-19 platform trial in care homesPhilip M Bath, Jonathan Ball, Matthew Boyd, et al.
Diagnostic and Prognostic Research|May 17, 2019
Erratum to: Methods for evaluating medical tests and biomarkersGowri Gopalakrishna, Miranda Langendam, Rob Scholten, et al.
Pageof 13